Rothia mucilaginosa bacteremia in end-stage renal disease and solid organ transplant: the need for raised awareness. Infez Med 2019 Mar 01;27(1):82-84
Date
03/19/2019Pubmed ID
30882384Scopus ID
2-s2.0-85063293350 3 CitationsAbstract
Rothia mucilaginosa, previously known as Stomatococcus mucilaginosus, is a Gram-positive coccus that is a part of the oropharyngeal and upper respiratory tract microbiota. Although this organism is believed to be of low virulence, it is increasingly being recognized as an opportunistic pathogen mostly affecting immunocompromised hosts. In this article, we describe a case of Rothia mucilaginosa bacteremia in an immunocompromised heart transplant recipient with end-stage renal disease, who was getting maintenance hemodialysis via a tunneled catheter. To the best of our knowledge, no cases of Rothia mucilaginosa bacteremia have been reported previously in heart transplant patients.
Author List
Bejjanki H, Koratala AAuthor
Abhilash Koratala MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Actinomycetales InfectionsAwareness
Bacteremia
Female
Heart Transplantation
Humans
Immunocompromised Host
Kidney Failure, Chronic
Micrococcaceae
Middle Aged
Renal Dialysis
Transplant Recipients
